Factors Influencing Chronic Hepatitis C Treatment Results - Tolmane, Ieva;Rozentale, Baiba;Simanis, Raimonds
16,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
payback
8 °P sammeln
  • Broschiertes Buch

Due to its distribution and clinical course, chronic viral hepatitis C has become one of the most common infectious diseases in the world. At present the number of the infected in the world is about 170 million, but in Europe it exceeds 9 million. The incidence of chronic viral hepatitis C in Latvia is relatively high. The antibody prevalence is 2.4%, HCV-RNA prevalence is 1.7%, it means that in Latvia there might be almost 40 000 chronic hepatitis C patients. This study gives an opportunity to calculate positive treatment result possibility for every chronic viral hepatitis C patient.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Due to its distribution and clinical course, chronic viral hepatitis C has become one of the most common infectious diseases in the world. At present the number of the infected in the world is about 170 million, but in Europe it exceeds 9 million. The incidence of chronic viral hepatitis C in Latvia is relatively high. The antibody prevalence is 2.4%, HCV-RNA prevalence is 1.7%, it means that in Latvia there might be almost 40 000 chronic hepatitis C patients. This study gives an opportunity to calculate positive treatment result possibility for every chronic viral hepatitis C patient.
Autorenporträt
Ieva Tolmane is working at Riga East university hospital, hospital ¿State Infectology Center¿ as a head of Hepatology department. At the same time she is assistant professor at University of Latvia. Her medical interest is chronic viral hepatitis C, which was the theme of her PhD thesis.